However, BBS is a rare disease with a small patient population for which there are no other targeted pharmacotherapies, and the 14-week, exploratory, placebo-controlled outcomes provide some supportive comparative effectiveness evidence
This confirms that the - is a safe, effective, and non-invasive solution for supporting weight management, appetite control, and blood sugar balance
NICE guidance on type 2 diabetes management (NG28) emphasises individualised treatment approaches and shared decision-making between patients and healthcare providers
The mean BMI was 34.0 kg/m2
GLP-1 Medication If your provider determines you are a candidate, your GLP-1 medication is prescribed and fulfilled by an FDA-regulated compounding or specialty pharmacy